Pipeline opportunity
Translate your mission, current patient population, and portfolio gaps into a focused product brief. Identify assets and dosage-form concepts worth pursuing.
Strategic partnerships
We pair the capital with the chemistry.
The right opportunity needs more than an introduction. It needs partners whose capabilities and goals fit.
Capital & mandate matches
Government grants and subsidies, funds chartered to develop assets, and partners pursuing Phase 1–Phase 2 licensing or acquisition. Match the program to the money that already exists for it.
Formulation & manufacturing matches
Connect CMO/CDMO and formulation R&D teams with sponsors whose products fit their capabilities. Align the clinical rationale, technical needs, and commercial goals.
Distribution-led partnerships
Pair product concepts with organizations that already reach the relevant patients. Assess the care setting, access model, and route to market before choosing the product.
Cross-border connections
Explore US opportunities for products approved abroad and international opportunities for FDA-approved assets. Connect clinical and market analysis with licensing, distribution, and specialist regulatory partners.
Strategic planning
Technology transfer, pipeline development, and portfolio reviews. Keep the mandate, the asset list, and the partner mix aligned as the pipeline grows.
Who belongs at the table
Funding partners & family offices
Government grant & subsidy programs
Funds with asset-development mandates
Mission-led NGOs & nonprofits
Business development, licensing & tech transfer
Formulation, CMO/CDMO & distribution partners
Pipeline mandates of $50M+, plus institutions, nonprofits, and funds building patient-led portfolios with grant, subsidy, or acquisition capital. Our role is opportunity alignment and partner matchmaking; legal, regulatory execution, and investment decisions stay with the appropriate specialists.
The next connection